The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats
- 1 June 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 63 (6), 2123-2133
- https://doi.org/10.1046/j.1523-1755.2003.00027.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratKidney International, 2002
- Protein Glycation, Diabetes, and AgingRecent Progress in Hormone Research, 2001
- Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation ReactionsPublished by Elsevier BV ,2000
- The Metabolic Syndrome XAnnals of the New York Academy of Sciences, 1999
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999
- Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 1996
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- HYPERTENSIVE DIABETIC RATS IN PHARMACOLOGICAL STUDIESPharmacological Research, 1996
- The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.Hypertension, 1992
- Analysis of B-6 vitamers and pyridoxic acid in plasma, tissues and urine using high performance liquid chromatographyNutrition Research, 1989